Skip to content

Patient Empowerment and Agency Through Intrapartum Counseling and Education

PEAICE: Patient Empowerment and Agency Through Intrapartum Counseling and Education: a Randomized Controlled Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06787521
Acronym
PEAICE
Enrollment
216
Registered
2025-01-22
Start date
2025-04-01
Completion date
2026-02-28
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy Related

Keywords

Intrapartum, Labor Agency

Brief summary

A single-blind randomized controlled trial to study the effects of a labor guide on perceived control in labor. The experimental arm will receive an evidence-based labor guide at the time of admission for scheduled induction of labor. The control arm will receive the standard of care in-person counseling regarding options for labor interventions

Detailed description

Participants will be randomized to receive an evidence-based labor guide at the time of admission for scheduled induction of labor, or the standard of care. Following delivery, patients will be surveyed about their labor experience. Chart review will be done to collect data on obstetric interventions and outcomes and neonatal outcomes.

Interventions

OTHERevidence-based labor guide

Participants will be provided with written education about potential complications and interventions. Information will be provided at the time of admission for labor induction.

Sponsors

Oregon Health and Science University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

1:1 randomization will be done using REDCap.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Nulliparous * Singleton pregnancy * English-speaking * Undergoing induction of labor for a medical or elective indication * Reached at least 36 weeks 0 days gestation * Willing and able to sign a consent form * Delivering at OHSU

Exclusion criteria

* Undergoing induction termination * Fetal complications such as multiple gestation, major fetal anomalies, fetal demise * Decisionally-impaired adults * Minors

Design outcomes

Primary

MeasureTime frameDescription
Labor Agentry Scale-10 (LAS-10)1-7 days following deliveryA validated questionnaire that measures patient-perceived control during labor

Secondary

MeasureTime frameDescription
Labor InterventionsDuring laborWhether patients received labor interventions including Pitocin, misoprostol, cook balloon, intra-uterine pressure catheter, manual rotation
Maternal hyper/hypotensionDuring induction of laborWhether the patient experience hypertension or hypotension
Intrapartum blood lossLabor and deliveryThe amount of blood loss a patient experienced during delivery
Cesarean sectionDeliveryWhether a patient requires a cesarean delivery
Time to deliveryAdmission for induction to deliveryThe duration from admission for induction to delivery

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORFei Cai, MD

Oregon Health and Science University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 21, 2026